VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.
Molecular Weight:
516.3363
CAS Number:
[1793080-72-4]
Formula:
C21H17F4N2O7P
* VAT and and shipping costs not included. Errors and price changes excepted